Biopac India Corporation Limited reported unaudited standalone earnings results for the second quarter and six months ended Sept. 30, 2018. For the quarter, the company reported revenue from operations (net of excise duty) of INR 45.988 million, loss from operations before exceptional items and tax of INR 77.378 million, loss before tax of INR 77.378 million and net loss after tax of INR 77.717 million or INR 4.51 per basic and diluted share compared to revenue from operations (net of excise duty) of INR 122.258 million, profit from operations before exceptional items and tax of INR 0.764 million, profit before tax of INR 0.764 million and net profit after tax of INR 1.178 million or INR 0.07 per basic and diluted share reported in the same period last year. For the six months, the company reported revenue from operations (net of excise duty) of INR 143.025 million, loss from operations before exceptional items and tax of INR 127.925 million, loss before tax of INR 127.925 million and net loss after tax of INR 128.040 million or INR 7.42 per basic and diluted share compared to revenue from operations (net of excise duty) of INR 235.304 million, profit from operations before exceptional items and tax of INR 5.022 million, profit before tax of INR 5.022 million and net profit after tax of INR 4.721 million or INR 0.27 per basic and diluted share reported in the same period last year.